Trial no.:
|
PACTR201701001868213 |
Date of Approval:
|
14/11/2016 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Comparing 2 medications in management of necrotic pulp in primary molars |
Official scientific title |
Evaluation of Postoperative Pain after Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy: A Randomized Controlled Trial |
Brief summary describing the background
and objectives of the trial
|
to compare 2 medications in treating necrotic primary molars in children one is gold standard and called calcium hydroxid iodofrom paste and the comarator is in innovative called 3-mixtatin , the objective is to treat hopless primary molars by the newly introduced material |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
necrotic primary molars |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
30/11/2016 |
Actual trial start date |
01/12/2016 |
Anticipated date of last follow up |
01/08/2017 |
Actual Last follow-up date |
01/09/2016 |
Anticipated target sample size (number of participants) |
92 |
Actual target sample size (number of participants) |
92 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|